Cytosolic and luminal peptidases

Generic cytosolic and luminal peptidases encompass a wide array of enzymes, including aminopeptidases, carboxypeptidases, and endopeptidases, that reside within the cell's cytoplasm or the interior of organelles like the endoplasmic reticulum (Source: UniProt). These enzymes are fundamental to cellular health, performing tasks such as the degradation of misfolded proteins, the recycling of amino acids, and the processing of bioactive peptides (Source: PubMed). In the immune system, specific luminal peptidases like ERAP1 and ERAP2 are crucial for processing antigens for presentation on MHC class I molecules (Source: NIH). In drug development, this collective group is frequently referenced regarding the metabolism and activation of peptide-linked prodrugs, such as valacyclovir, which rely on enzymatic cleavage to release the active therapeutic moiety (Source: PubChem). Because this term describes a functional class rather than a single molecular entity, it is generally utilized in pharmacokinetic modeling to account for broad proteolytic activity. Consequently, it is not considered a specific therapeutic target, and attempting to modulate the entire class would likely result in significant toxicity due to their essential roles in global protein turnover. Specific inhibitors like bestatin have been studied for their ability to modulate these enzymes in cancer and infectious diseases, though clinical utility is often limited by lack of specificity (Source: PubMed).

Other names

Intracellular peptidasesCytoplasmic proteasesLuminal proteasesEndopeptidasesExopeptidasesAminopeptidasesCarboxypeptidases

These enzymes catalyze the hydrolysis of peptide bonds, often utilizing a zinc ion or a serine, cysteine, or threonine residue to facilitate the nucleophilic attack on the carbonyl carbon of the substrate, leading to the cleavage of the peptide chain.